Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-030-3 | CAS number: 65996-95-4 Substance obtained by acidulating phosphate rock with phosphoric acid. Normally characterized as containing 40% or more available phosphoric oxide (P2O5). Composed primarily of calcium phosphate.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No reliable skin irritation study with triple superphosphate is available. Based on a reliable in vivo study with ammonium dihydrogenorthophosphate showing no or minimal irritation, it is concluded that that the substance is not irritating to skin. This was confirmed with a reliable skin irritation study with calcium bis(dihydrogenorthophosphate). Based upon a reliable in vivo eye irritation study with triple superphosphate, the substance is considered an eye irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation
- Remarks:
- no data
- Type of information:
- not specified
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: data not retrieved; secondary source
- Reason / purpose for cross-reference:
- reference to same study
- Guideline:
- other: not mentioned
- Principles of method if other than guideline:
- no data
- GLP compliance:
- not specified
- Strain:
- not specified
- Vehicle:
- not specified
- Controls:
- not specified
- Duration of treatment / exposure:
- no data
- Observation period (in vivo):
- no data
- Number of animals or in vitro replicates:
- no data
- Conclusions:
- mild irritant
Reference
mild irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Data on skin irritation/corrosion of triple superphosphate is not available. The assessment of skin irritation/corrosion was therefore based on studies conducted with reference substances as part of a read across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the read-across approach is provided in the technical dossier (see IUCLID Section 13) and within Chapter 5.1 of the CSR.
Skin irritation
No reliable study with triple superphosphate is present. In a reliable skin irritation study performed comparable to OECD 404 guideline, ammonium dihydrogenorthophosphate does show some effects on the erythema, which are minimal and fully reversible within 72 hours. In addition, a reliable study with calcium bis(dihydrogenorthophosphate) is available, performed according to the relevant guidelines (EU and US), and the substance was not irritating. This was confirmed in supporting studies.
Eye irritation
In a reliable eye irritation study performed according to OECD 405 guideline, EC B.5, EPA and JMAFF guidelines, triple superphosphate does show serious eye damaging effects. Instillation of approximately 69 mg of Superphosphate, concd. (TSP powder) (a volume of approximately 0.1 mL) into one eye of each of three rabbits resulted in effects on the cornea, iris and/or conjunctivae. Corneal injury was observed in one animal behind the lower eyelid and consisted of opacity (maximum grade 3) and epithelial damage (maximum 25% of the corneal area). As a result of the corneal injury, pannus (neovascularization of the cornea) was apparent 14 and 21 days after instillation. In this same animal irritation of the conjunctivae (consisting of redness, chemosis and discharge) remained present up to the end of the 21-day observation period, along with gray/white discolouration of the nictating membrane and lower eyelid (sign of necrosis). Reduced elasticity of both eyelids was also observed for this animal. Irritation of the conjunctivae among the other two animals also consisted of redness, chemosis and discharge, and had completely resolved within 7 or 14 days. Iridial irritation grade 1 was observed in two animals and had resolved within 24 or 72 hours. No symptoms of systemic toxicity were observed in the animals during the test period and no mortality occurred.
Justification for selection of skin irritation / corrosion endpoint:
Hazard assessment is conducted by means of read-across based on a category approach. All available studies are adequate and reliable based on the identified similarities in structure and intrinsic properties between the source and target substances and overall quality assessment (refer to the endpoint discussion for further details).
Justification for selection of eye irritation endpoint:
The reliable GLP compliant OECD Guideline study was chosen.
Effects on eye irritation: corrosive
Justification for classification or non-classification
Based on the available data, triple superphosphate does not have to be classified according to Directive 67/548/EC and the CLP Regulation for skin irritation. However, classification for eye irritation is required: according to CLP Regulation Cat. 1, Causes serious eye damage, H318, and according to Directive 6/548/EC it should be classified as irritant, Xi, and Risk of serious damage to eyes, R41.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
